Visual function linked to preBCVA in AMD cataract patients

Article

Visual function improves in eyes with age-related macular degeneration (AMD) that have undergone cataract surgery, but the extent of the improvement depends on the eye’s preoperative best-corrected visual acuity (preBCVA), according to a new retrospective analysis published in Investigative Ophthalmology and Visual Science.

Visual function improves in eyes with age-related macular degeneration (AMD) that have undergone cataract surgery, but the extent of the improvement depends on the eye’s preoperative best-corrected visual acuity (preBCVA), according to a new retrospective analysis published in Investigative Ophthalmology and Visual Science.

Related: Radiotherapy system receives CE mark extension

The US investigators studied 4,924 cataract surgeries on eyes with AMD for which preoperative and postoperative NEI-VFQ-25 questionnaires had been submitted. All were from the VA Ophthalmic Surgical Outcomes Data Project. The researchers compared outcomes in these eyes with outcomes in control eyes that did not have retinal pathology, looking at changes in visual acuity and improvement in overall visual function and its subscales.

Analysing overall scores, the investigators found that, for eyes with a preBCVA of ≥20/40, the improvement in visual function was similar to that seen in patients without retinal pathology. If the eye’s preBCVA was <20/40, however, then there was a lesser degree of improvement; the amount of improvement decreased with decreasing preBCVA. 

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.